搜尋結果
US FDA declines to approve Rocket Pharma's immune disorder gene therapy
Reuters· 1 日前The company was seeking its first approval from the agency to use the therapy to treat patients ...
10 of the most exciting digital health startups of 2024, according to VCs
TechCrunch· 4 日前In the post-COVID world, VCs say it’s not as easy to get excited about investing in digital ...
Alnylam's heart disease drug meets main goal in late-stage study
Reuters· 5 日前, opens new tab said on Monday that its drug vutrisiran met the main goal in a late-stage study testing it as a treatment ...
Marijuana Overdoses Are Rising Among The Elderly
Forbes· 6 日前Marijuana poisonings rose sharply among people 65 years of age and older, after Canada ...
Cosmetic Surgery Trends: Weight Loss Drugs Drove Spike In Fillers And Facelifts Last Year, ...
Forbes· 4 日前The American Society of Plastic Surgeons found a 5% increase in plastic surgeries and a 7% ...
Stolen Data Across UK Signals Hospital Hack Worse Than Disclosed
Bloomberg· 3 日前Hackers behind a London hospital attack recently published records that include personal ...
Access, security challenge Gaza aid delivery, block medical evacuations: UN
China Daily· 4 日前The UN Office for the Coordination of Humanitarian Affairs (OCHA) said the inability to transport aid commodities from the ...
Council Post: How AI Is Expanding The Mental Health Market
Forbes· 4 日前Eugene Klishevich is the Founder and CEO of Moodmate Inc. and an Impact Entrepreneur in AI and ...
As Walmart Closes Clinics, Buyer Emerges For Its Telehealth Business
Forbes· 1 日前Walmart is selling its virtual healthcare business to Fabric, a fast-growing provider of ...
Alnylam Pharma Shares Surge 30% After Rare Heart Disease Drug Succeeds
Forbes· 5 日前Shares of Alnylam Pharmaceuticals rose by over 32%, the company’s largest single-day gain in ...